+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Monoclonal Antibodies In Veterinary Health Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
Monoclonal Antibodies In Veterinary Health Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
New

Monoclonal Antibodies In Veterinary Health Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 185 Pages
  • March 2025
  • Region: Global
  • TechSci Research
  • ID: 5908217
Free Webex Call
10% Free customization
Description Jump to:
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Global Monoclonal Antibodies In Veterinary Health Market was valued at USD 903.40 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 15.50% through 2030. The global monoclonal antibodies (mAbs) in veterinary health market represents a rapidly growing segment within the broader animal healthcare industry. Monoclonal antibodies, which are lab-engineered antibodies that can target specific antigens, are increasingly being adopted in veterinary medicine for their therapeutic and diagnostic applications.

Key Market Drivers

Increasing Companion Animal Ownership and Pet Humanization

The increasing trend of companion animal ownership, coupled with the growing humanization of pets, is a major driver of the Global Monoclonal Antibodies (mAbs) in the Veterinary Health Market. Over 50% of the global population is estimated to own a pet, with dogs being the most prevalent, found in approximately 33% of households worldwide. Cats are the second most popular choice, owned by nearly 25% of pet-keeping households. This widespread pet ownership trend reflects a significant and growing market opportunity for pet-related industries, including food, healthcare, accessories, and services, driven by increasing consumer demand and the human-animal bond. As pet owners demand higher-quality healthcare solutions for their animals, the market for advanced veterinary therapeutics, including monoclonal antibody-based treatments, is experiencing significant growth.

Households in the U.S., EU, and China collectively own over 500 million dogs and cats, underscoring a massive and expanding market for pet healthcare solutions. In the U.S., pet ownership grew from 68% of households in 2016 to 70% in 2021, reflecting a sustained upward trend in companion animal adoption and increased consumer spending on veterinary care. Over the past decade, there has been a significant increase in pet adoption rates, particularly in developed economies such as North America, Europe, and parts of Asia-Pacific. Factors such as rising disposable incomes, changing lifestyles, and a growing preference for emotional companionship have contributed to this trend. With pet ownership on the rise, there is a corresponding increase in demand for effective veterinary treatments, including monoclonal antibodies for conditions such as arthritis, dermatological disorders, and cancer.

Key Market Challenges

High Development Costs

Developing monoclonal antibodies is a complex and expensive process. Research and development costs can be prohibitively high, which poses a significant challenge for smaller biotech companies and startups looking to enter the market. These high costs can limit the diversity of players and the range of mAb products available.

Key Market Trends

Expansion of Targeted Therapies

One of the most significant upcoming trends is the expansion of targeted therapies using monoclonal antibodies. As our understanding of animal diseases and their molecular mechanisms deepens, researchers are developing mAbs that can target specific disease pathways with precision. This trend promises to provide veterinarians with a broader range of effective treatment options for a variety of conditions.

Key Market Players

  • Zoetis Inc.
  • Merck & Co., Inc.
  • Elanco LLC
  • Boehringer Ingelheim GmbH
  • Indian Immunologicals Ltd
  • Virbac SA

Report Scope:

In this report, the Global Monoclonal Antibodies In Veterinary Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Monoclonal Antibodies In Veterinary Health Market, By Animal Type:

  • Dogs
  • Others

Monoclonal Antibodies In Veterinary Health Market, By Application:

  • Dermatology
  • Pain
  • Others

Monoclonal Antibodies In Veterinary Health Market, By End-User:

  • Veterinary Hospitals
  • Others

Monoclonal Antibodies In Veterinary Health Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Monoclonal Antibodies In Veterinary Health Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Monoclonal Antibodies In Veterinary Health Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Animal Type (Dogs, Others)
5.2.2. By Application (Dermatology, Pain, Others)
5.2.3. By End-User (Veterinary Hospitals, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Product Market Map
5.3.1. By Animal Type
5.3.2. By Application
5.3.3. By End-User
5.3.4. By Region
6. North America Monoclonal Antibodies In Veterinary Health Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Animal Type (Dogs, Others)
6.2.2. By Application (Dermatology, Pain, Others)
6.2.3. By End-User (Veterinary Hospitals, Others)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Monoclonal Antibodies In Veterinary Health Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Animal Type
6.3.1.2.2. By Application
6.3.1.2.3. By End-User
6.3.2. Canada Monoclonal Antibodies In Veterinary Health Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Animal Type
6.3.2.2.2. By Application
6.3.2.2.3. By End-User
6.3.3. Mexico Monoclonal Antibodies In Veterinary Health Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Animal Type
6.3.3.2.2. By Application
6.3.3.2.3. By End-User
7. Europe Monoclonal Antibodies In Veterinary Health Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Animal Type (Dogs, Others)
7.2.2. By Application (Dermatology, Pain, Others)
7.2.3. By End-User (Veterinary Hospitals, Others)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Monoclonal Antibodies In Veterinary Health Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Animal Type
7.3.1.2.2. By Application
7.3.1.2.3. By End-User
7.3.2. United Kingdom Monoclonal Antibodies In Veterinary Health Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Animal Type
7.3.2.2.2. By Application
7.3.2.2.3. By End-User
7.3.3. France Monoclonal Antibodies In Veterinary Health Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Animal Type
7.3.3.2.2. By Application
7.3.3.2.3. By End-User
7.3.4. Italy Monoclonal Antibodies In Veterinary Health Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Animal Type
7.3.4.2.2. By Application
7.3.4.2.3. By End-User
7.3.5. Spain Monoclonal Antibodies In Veterinary Health Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Animal Type
7.3.5.2.2. By Application
7.3.5.2.3. By End-User
8. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Animal Type (Dogs, Others)
8.2.2. By Application (Dermatology, Pain, Others)
8.2.3. By End-User (Veterinary Hospitals, Others)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Monoclonal Antibodies In Veterinary Health Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Animal Type
8.3.1.2.2. By Application
8.3.1.2.3. By End-User
8.3.2. Japan Monoclonal Antibodies In Veterinary Health Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Animal Type
8.3.2.2.2. By Application
8.3.2.2.3. By End-User
8.3.3. India Monoclonal Antibodies In Veterinary Health Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Animal Type
8.3.3.2.2. By Application
8.3.3.2.3. By End-User
8.3.4. Australia Monoclonal Antibodies In Veterinary Health Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Animal Type
8.3.4.2.2. By Application
8.3.4.2.3. By End-User
8.3.5. South Korea Monoclonal Antibodies In Veterinary Health Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Animal Type
8.3.5.2.2. By Application
8.3.5.2.3. By End-User
9. South America Monoclonal Antibodies In Veterinary Health Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Animal Type (Dogs, Others)
9.2.2. By Application (Dermatology, Pain, Others)
9.2.3. By End-User (Veterinary Hospitals, Others)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Monoclonal Antibodies In Veterinary Health Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Animal Type
9.3.1.2.2. By Application
9.3.1.2.3. By End-User
9.3.2. Argentina Monoclonal Antibodies In Veterinary Health Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Animal Type
9.3.2.2.2. By Application
9.3.2.2.3. By End-User
9.3.3. Colombia Monoclonal Antibodies In Veterinary Health Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Animal Type
9.3.3.2.2. By Application
9.3.3.2.3. By End-User
10. Middle East and Africa Monoclonal Antibodies In Veterinary Health Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Animal Type (Dogs, Others)
10.2.2. By Application (Dermatology, Pain, Others)
10.2.3. By End-User (Veterinary Hospitals, Others)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Monoclonal Antibodies In Veterinary Health Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Animal Type
10.3.1.2.2. By Application
10.3.1.2.3. By End-User
10.3.2. Saudi Arabia Monoclonal Antibodies In Veterinary Health Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Animal Type
10.3.2.2.2. By Application
10.3.2.2.3. By End-User
10.3.3. UAE Monoclonal Antibodies In Veterinary Health Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Animal Type
10.3.3.2.2. By Application
10.3.3.2.3. By End-User
10.3.4. Kuwait Monoclonal Antibodies In Veterinary Health Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Animal Type
10.3.4.2.2. By Application
10.3.4.2.3. By End-User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Porter’s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Competitive Landscape
14.1. Zoetis Inc.
14.1.1. Business Overview
14.1.2. Product & Service Offering
14.1.3. Recent Developments
14.1.4. Financials (as reported)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. Merck & Co., Inc.
14.3. Elanco LLC
14.4. Boehringer Ingelheim GmbH
14.5. Indian Immunologicals Ltd
14.6. Virbac SA
15. Strategic Recommendations16. About the Publisher & Disclaimer

Companies Mentioned

  • Zoetis Inc.
  • Merck & Co., Inc.
  • Elanco LLC
  • Boehringer Ingelheim GmbH
  • Indian Immunologicals Ltd
  • Virbac SA

Table Information

Report AttributeDetails
No. of Pages185
PublishedMarch 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 903.4 Million
Forecasted Market Value ( USD ) by 2030 $ 2140 Million
Compound Annual Growth Rate15.5%
Regions CoveredGlobal
No. of Companies Mentioned6

Related Topics

Related Reports

Monoclonal Antibodies Market Report and Forecast 2024-2032 - Product Image

Monoclonal Antibodies Market Report and Forecast 2024-2032

  • Report
  • 160 Pages
  • Global
From
Antibodies Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Antibodies Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Monoclonal Antibodies (mAbs) Global Market Opportunities and Strategies to 2033 - Product Image

Monoclonal Antibodies (mAbs) Global Market Opportunities and Strategies to 2033

  • Report
  • 279 Pages
  • Global
From
Research Antibodies Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Research Antibodies Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Biosimilar Monoclonal Antibodies Market by Drug Class, Application - Global Forecast 2025-2030 - Product Image

Biosimilar Monoclonal Antibodies Market by Drug Class, Application - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.